PIONEER-HF: In-Hospital ARNI Shows Biomarker Benefit vs ACE-I PIONEER-HF: In-Hospital ARNI Shows Biomarker Benefit vs ACE-I

Prognostically powerful natriuretic peptides fell further in patients with stabilized, recently decompensated heart failure who were started in hospital on sacubitril/valsartan compared with enalapril.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news